Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

British Journal of Ophthalmology

Volumn 87, Issue 6, 2003, Pages 763-766

  Van Kooij, Bram ^a   Canninga Van Dijk, M ^a   De Boer, J ^a   Sigurdsson, V ^a   Rothova, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; EYE SURGERY; FEMALE; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; GRANULOMA ANNULARE; HUMAN; HUMAN TISSUE; INTERMEDIATE UVEITIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA VASCULITIS; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SKIN BIOPSY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GRANULOMA ANNULARE; HUMANS; MALE; MIDDLE AGED; RETINAL VASCULITIS; RETROSPECTIVE STUDIES; UVEITIS, INTERMEDIATE;

EID: 0038694679     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.6.763     Document Type: Article

References (19)

1. Park DW, Folk JC, Whitcup SM, et al. Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation. Arch Ophthalmol 1998;116:1025-9.
2. Boskovich SA, Lowder CY, Meisler DM, et al. Systemic diseases associated with intermediate uveitis. Cleve Clin J Med 1993;60:460-5.
3. Zierhut M, Foster CF. Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol 1992;23:41-7.
4. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993;100:818-25.
5. Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 1993;100:1199-205.
6. Lupton JR, Figueroa P, Berberian BJ, et al. Can granuloma annulare evolve into cutaneous sarcoidosis? Cutis 2000;66:390-2.
7. Braun-Falco O, Plewig G, Wolff HH, et al. Granuloma annulare. In: Braun-Falco O, ed. Dermatology. 2nd ed Berlin: Springer-Verlag, 2000:1387-89
8. Ehrich EW, McGuire JL, Kim YH. Association of granuloma annulare with sarcoidosis. Arch Dermatol 1992;128:855-6.
9. Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestations of sarcoidosis. Am J Dermatopathol 1995;17:18-22.
10. Bloch-Michel E, Nussenblatt RB. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;103:234-5.
11. Althaus C, Sundmacher R. Intermediate uveitis: epidemiology, age and sex distribution. Dev Ophthalmol 1992;23:9-24.
12. Dinning WJ. Intermediate uveitis: history, terminology, definition. Pars planitis: systemic disease associations. Dev Ophthalmol 1992;23:3-8.
13. Andersen BL, Verdich J. Granuloma annulare and diabetes mellitus. Clin Exp Dermatol 1979;4:31-7.
14. El-Shabrawi YG, Christen WG, Foster SC. Correlation of metalloproteinase-2 and -9 with cytokines interleukin-1 b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr Eye Res 2000;20:211-14.
15. Wallace GR, Whiston RA, Standford MR, et al. The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin Exp Immunol 1999;118:364-70.
16. Fayyazi A, Schweyer S, Eichmeyer B, et al. Expression of IFNα, coexpression of TNFα and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 2000;292:384-90.
17. Vaalamo M, Kariniemi AL, Shapiro SD, et al. Enhanced expression of human metalloproteinase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol 1999;112:499-505.
18. Sethi CS, Bailey TA, Chong NHV. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol 2000;84:654-6.
19. Böke W. Clinical picture of intermediate uveitis. Dev Ophthalmol 1992;23:20-7.